NCT00169195 - Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions

Diffuse Large Cell Lymphoma

Interventions

DRUG

Gemcitabine-Oxaliplatin plus Rituximab (R-GEMOX)

Trial Locations (8)

Hôpital Henri Mondor, Créteil

Service d'Hématologie Clinique - CHU Le Bocage, Dijon

Service des Maladies du Sang - CHRU de Lille, Lille

Centre Léon Bérard, Lyon

Hôpital Saint Louis, Paris

Service D'Hématologie Adulte - Hôpital Necker, Paris

Centre Henri Becquerel, Rouen

CHRU de Nancy Brabois, Vandœuvre-lès-Nancy